**Appendices and nomenclature**


**65**

**Author details**

Nilay Seyidoglu1

\* and Cenk Aydin<sup>2</sup>

\*Address all correspondence to: nseyidoglu@nku.edu.tr

Kemal University, Tekirdag, Turkey

provided the original work is properly cited.

University, Bursa, Turkey

1 Department of Physiology, Faculty of Veterinary Medicine, Tekirdag Namik

2 Department of Physiology, Faculty of Veterinary Medicine, Bursa Uludag

© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium,

*Saccharomyces: Is a Necessary Organism or a Biological Warrior?*

*DOI: http://dx.doi.org/10.5772/intechopen.96029*

*Saccharomyces: Is a Necessary Organism or a Biological Warrior? DOI: http://dx.doi.org/10.5772/intechopen.96029*

*Saccharomyces*

**6. Conclusion**

**Conflict of interest**

**Acronyms and abbreviations**

**Appendices and nomenclature**

Nucleosomes DNA, RNA

Single celled organism *Saccharomyces cerevisiae*

Biopharmaceuticals insulin and its analogs

the generation of immune responses.

diversity of yeast strains will improve in the future.

The authors declare no conflict of interest.

HIV Human immunodeficiency virus SARS Severe Acute Respiratory Syndrome

FDA U.S. Food and Drug Administration

Yeast The most important eukaryote; Saccharomyces.

a nuclear envelope

Eukaryotes The organisms whose cells have a nucleus enclosed within

COVID-2019 Coronavirus-disease 2019

DNA Deoxyribonucleic acid RNA Ribonucleic acid *S. cerevisiae Saccharomyces cerevisiae S. boullardii Saccharomyces boullardii S. carlsbergensis Saccharomyces carlsbergensis S. bayanus Saccharomyces bayanus S. pastorianus Saccharomyces pastorianus S. paradoxus Saccharomyces paradoxus S. ebayanus Saccharomyces ebayanus S. pombe Schizosaccharomyces pombe*

Yeast engineered to the virus has been accepted as an ideal therapeutic approach. This vaccine's strategy is improving humoral immunity due to the ability of yeast to

There is a numerous increasing study to obtain the vaccine strategy of yeasts. Studies in yeast proteins and cell wall components, including beta-glucan, may become more critical for vaccine strategies under different phases of clinical trials on animals or humans. According to the essential features of yeast, the yeast-based vaccine strategy is being necessary for vaccine development. It has foreseen that

The yeast system provides invaluable antiviral strategies. Significant studies have been conducted on yeast progression in the identification of viral diseases and antiviral strategies. Based on a better understanding of yeast protein and viruses, the search for new vaccines and medications for viral or pandemic diseases is safer and more effective. However, experiments with animal models and human cells are still underway in many types of yeast. Knowledge of these new biological systems and technologies, models, and organisms will open up new science avenues.

**64**
